List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 2171 studies with search of:   "Leukemia"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
21 Recruiting Single Versus Double Umbilical Cord Blood Transplantation in Children With High Risk Leukemia and Myelodysplasia
Conditions: Acute Myelogenous Leukemia;   Acute Lymphocytic Leukemia;   Chronic Myelogenous Leukemia;   Myelodysplastic Syndrome
Interventions: Biological: Single Cord Blood Unit Transplantation;   Biological: Double Cord Blood Unit Transplantation
22 Recruiting Busulfan, Fludarabine, Clofarabine With Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia
Conditions: Acute Myeloid Leukemia;   Myelodysplastic Syndrome;   Chronic Myeloid Leukemia
Interventions: Drug: Clofarabine;   Drug: Busulfan;   Drug: Fludarabine
23 Recruiting A Phase I Study of WT1 Peptides to Induce Anti-Leukemia Immune Responses Following Autologous or Allogeneic Transplantation for AML, CML, ALL, MDS, and B Cell Malignancies
Conditions: Acute Myelogenous Leukemia (AML);   Chronic Myelogenous Leukemia (CML);   Acute Lymphoblastic Leukemia (ALL);   Myelodysplastic Syndrome (MDS);   B Cell Malignancies
Intervention: Biological: WT1 derived peptides
24 Terminated Study of DT388GMCSF Fusion Protein in Acute Myelogenous Leukemia (AML) and Chronic Myelomonocytic Leukemia (CMML)
Conditions: Acute Myelogenous Leukemia;   Chronic Myelomonocytic Leukemia
Intervention: Drug: DT388GMCSF Fusion Protein
25 Completed A Study of Dasatinib in Patients With Chronic Myelogenous Leukemia Who Are Resistant or Intolerant of Imatinib Mesylate
Conditions: Leukemia, Myeloid, Chronic;   Leukemia, Lymphocytic, Acute, L2
Intervention: Drug: Dasatinib
26 Terminated A Notch Signalling Pathway Inhibitor for Patients With T-Cell Acute Lymphoblastic Leukemia/Lymphoma (ALL)
Conditions: Leukemia, Lymphoblastic, Acute, T-Cell;   Myelogenous Leukemia;   Chronic Lymphocytic Leukemia;   Myelodysplastic Syndromes
Intervention: Drug: MK0752, (Notch Inhibitor)
27 Active, not recruiting Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML
Conditions: Myeloid Leukemia, Chronic, Accelerated Phase;   Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
Interventions: Drug: dasatinib;   Drug: dasatinib;   Drug: dasatinib;   Drug: dasatinib
28 Suspended A Phase I Dose Escalation Combination Study in Patients With Chronic Myelogenous Leukemia (CML) and Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)
Conditions: Chronic Myelogenous Leukemia;   Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
Interventions: Drug: MK0457;   Drug: dasatinib
29 Recruiting 5-Azacytidine (Azacytidine; Vidaza) in Chronic Lymphocytic Leukemia
Conditions: Chronic Lymphocytic Leukemia;   Leukemia
Intervention: Drug: 5-Azacytidine
30 Active, not recruiting Study of Weekly Clofarabine for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia
Conditions: Chronic Lymphocytic Leukemia;   Leukemia
Intervention: Drug: Clofarabine
31 Not yet recruiting SCH 727965 in Patients With Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia (P04717)
Conditions: Leukemia, Myeloid, Acute;   Lymphoblastic Leukemia, Acute
Interventions: Drug: SCH 727965;   Drug: Gemtuzumab ozogamicin
32 Recruiting 8-Chloro-Adenosine in Chronic Lymphocytic Leukemia
Conditions: Leukemia;   Chronic Lymphocytic Leukemia
Intervention: Drug: 8-Chloro-Adenosine
33 Recruiting Homoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML)
Conditions: Myeloid Leukemia, Chronic;   Myeloid Leukemia, Chronic, Accelerated-Phase;   Blast Phase;   Myeloid Leukemia, Chronic, Chronic-Phase
Intervention: Drug: Homoharringtonine and Gleevec
34 Recruiting Oral Clofarabine in Chronic Lymphocytic Leukemia (CLL)
Conditions: Leukemia;   Chronic Lymphocytic Leukemia
Intervention: Drug: Oral Clofarabine
35 Completed Study of Weekly Motexafin Gadolinium (MGd) for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions: Chronic Lymphocytic Leukemia;   Small Lymphocytic Lymphoma;   Leukemia;   Lymphoma
Intervention: Drug: motexafin gadolinium
36 Recruiting Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia
Conditions: Leukemia;   Acute Lymphoblastic Leukemia
Interventions: Drug: Rituximab;   Drug: Cyclophosphamide (CTX);   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Dexamethasone;   Drug: Methotrexate (MTX);   Drug: Cytarabine;   Drug: G-CSF
37 Completed 6-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Blastic Phase Chronic Myelogenous Leukemia
Conditions: Leukemia;   Myelodysplastic Syndromes
Intervention: Drug: irofulven
38 Active, not recruiting A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL)
Conditions: Leukemia;   Leukemia, Lymphocytic, Chronic
Intervention: Drug: Motexafin gadolinium
39 Completed PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes
Intervention: Drug: bortezomib
40 Recruiting Identifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia;   Leukemia
Interventions: Drug: Fludarabine;   Drug: Cyclophosphamide;   Drug: Rituximab

Previous Page (1-20) Studies Shown (21-40) Next (41-60)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options